Edesa Biotech Announces Offering of Common Shares and Warrants for Approximately $23.1 Million

Filing content

The company expects to raise approximately $23.1 million in net proceeds through an offering of common shares and pre-funded warrants. Proceeds will be used for general corporate purposes, including working capital and R&D.